» Articles » PMID: 17184396

Evaluation of Response Scenarios to Potential Polio Outbreaks Using Mathematical Models

Overview
Journal Risk Anal
Specialty Public Health
Date 2006 Dec 23
PMID 17184396
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Appropriate response to polio outbreaks represents an important prerequisite for achieving and maintaining global polio eradication. We use an existing dynamic disease transmission model to evaluate the impact of different aspects of immunization campaigns in response to polio outbreaks occurring in previously polio-free areas. This analysis yields several important insights about response strategies. We find that delay in response represents a crucial risk factor for occurrence of large outbreaks and we characterize the tradeoffs associated with delaying the initial response to achieve better population coverage. We also demonstrate that controlling most potential outbreaks will likely require at least three immunization rounds, although the impact of the optimal interval between rounds varies. Finally, long after oral poliovirus vaccine cessation the choice of target age groups during a response represents an important consideration.

Citing Articles

Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame.

Badizadegan K, Thompson K PLOS Glob Public Health. 2025; 5(2):e0004168.

PMID: 39919149 PMC: 11805368. DOI: 10.1371/journal.pgph.0004168.


Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).

Badizadegan N, Wassilak S, Estivariz C, Wiesen E, Burns C, Bolu O Pathogens. 2024; 13(9).

PMID: 39338995 PMC: 11435063. DOI: 10.3390/pathogens13090804.


Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.

Thompson K, Badizadegan K Pathogens. 2024; 13(6).

PMID: 38921733 PMC: 11206708. DOI: 10.3390/pathogens13060435.


Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.

Sun Y, Keskinocak P, Steimle L, Kovacs S, Wassilak S Vaccine X. 2024; 18:100476.

PMID: 38617838 PMC: 11011220. DOI: 10.1016/j.jvacx.2024.100476.


Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation.

Kalkowska D, Wassilak S, Wiesen E, Estivariz C, Burns C, Badizadegan K Gates Open Res. 2023; 7:55.

PMID: 37547300 PMC: 10403636. DOI: 10.12688/gatesopenres.14511.1.